A Patient-Level Pooled Analysis of 2 Empagliflozin Trials of Left Ventricular Remodeling

J Card Fail. 2023 Aug;29(8):1218-1221. doi: 10.1016/j.cardfail.2023.05.017. Epub 2023 Jun 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Benzhydryl Compounds / therapeutic use
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucosides
  • Heart Failure* / drug therapy
  • Humans
  • Ventricular Function, Left
  • Ventricular Remodeling

Substances

  • Benzhydryl Compounds
  • empagliflozin
  • Glucosides